Overview of Clinical Trials and Post Marketing
Clinical trials are conducted to collect data regarding the safety and efficacy of new drug and device development. There are several steps and stages of approval in the clinical trials process before a drug or device can be sold in the consumer market, if ever. Postmarketing study commitments are studies required of or agreed to by a sponsor that are conducted after FDA has approved a product for marketing. FDA uses postmarketing study commitments to gather additional information about a product's safety, efficacy, or optimal use.
- Human Clinical Trial Phases
- Participating in a Clinical Trial
- Patient Education Resources
- Efficacy vs Effectiveness
- Multi Center Trials and Monitoring
- Regulatory Authorities and Ethics Committee
- Advanced Information Technology in Clinical Trials and Promoting Companies
- Postmarketing Clinical Trials
Related Conference of Overview of Clinical Trials and Post Marketing
Overview of Clinical Trials and Post Marketing Conference Speakers
Recommended Sessions
- Case Report in Clinical Trials
- Pharmacokinetics and Pharmacodynamics
- PV Consultings And Bussiness Opportunity
- Adverse Drug Reactions
- Â PV Data Base Managemaent
- Case Study
- Clinical Data Management
- Drug Safety
- Entrepreneurs Investment Meet
- Good Pharmacovigilance Practice
- Growth Strategies in Pharma
- Overview of Clinical Trials and Post Marketing
- Pharmacovigilance on Biopharmaceutics
- Pharmacovigilance Risk management plans and new risk- benefit analysis tools
- Pharmacy Practices and its Challenges
- Preclinical and Clinical Trials on Various Disorders
- Regulatory Affairs